Anti-prothymosin α polyclonal antibody and its preparation method and application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- XIAMEN UNIV
- Publication Date
- 2011-12-28
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to an anti-thymosin pro-alpha polyclonal antibody, in particular to an anti-thymosin pro-alpha polyclonal antibody and its preparation method and application. Background technique
[0002] Worldwide, the incidence of bladder cancer ranks ninth among malignant tumors, and it is the most common tumor in the urinary system. In the United States, the incidence of bladder cancer ranks fourth among male malignancies, after prostate cancer, lung cancer, and colon cancer, and ranks ninth among female malignancies. In my country, it ranks 7th in male malignant tumors and 10th in females, with an incidence rate of about 7.4 / 100,000. The degree of malignancy of bladder cancer is not very high, and the 5-year survival rate of early diagnosis and treatment is 93%, but if the diagnosis and treatment cannot be detected in time, the 5-year survival rate of advanced patients is only 6%, and the mortality rate is much higher than that of bladder c...